BioVeda China Fund (BVCF) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, and Bejing
Employees: 11-50
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 14.07.2026 | Drug Farm | drug-farm.com | $111M | China |
Persons 3
| Date | First Name | Last Name | Title | Location | |||
| - | Huacheng | Wei | Adviser | - | - | - | |
| - | Bing | Zhuo | Adviser | - | - | - | |
| - | Yunlong | Huang | Adviser | - | - | - |
Mentions in press and media 10
| Date | Title | Description |
| 20.07.2026 | Drug Farm Secures $55 Million Series D, Accelerating AI-Powered Drug Development | Drug Farm closed a $55M Series D, fueling its AI-driven drug pipeline. The NYC-Shanghai biotech will advance clinical programs for DF-003, targeting ROSAH syndrome and cardiovascular disease, and DF-006 for hepatitis B. Its proprietary plat... |
| 14.07.2026 | Drug Farm Raises $55M in First Close of Series D Funding | Drug Farm, a NYC- and Shanghai, China-based biotechnology company developing novel drug targets, raised $55M in first close of its Series D financing. The round was Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collabor... |
| 31.01.2025 | Houston's Biotech Revolution: A New Dawn in Cancer Treatment | In the heart of Houston, a biotech revolution is brewing. Cellenkos Therapeutics, a female-founded company, is making waves with its innovative approach to treating myelofibrosis, a rare and challenging blood cancer. This breakthrough could... |
| 29.01.2025 | Play it back: Houston home tech startup begins 2025 with fresh funding | One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their main... |
| 07.05.2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay City Capital, Brunnur Ventures, EarlyBird, funds managed by Tekla Cap... |
| 07.05.2021 | Oculis closes US$57 million Series C financing | |
| 18.04.2016 | Lifescience-focussed BioVeda China Fund seeks $400m for fourth vehicle | Premium China-based investment firm with a focus on life sciences BioVeda China Fund (BVCF) is working on launching a $400 million fund, according to China Money Network quoting unnamed sources. Continue reading this story with a subscripti... |
| 09.01.2015 | DiaCarta Raises $8M in Series A Financing | DiaCarta, Inc., a Hayward, CA-based biotechnology company, raised $8m in Series A financing. Shanghai-based BioVeda China Fund made the investment. The company intends to use the funds to expand its product portfolio and support global comm... |
| 06.02.2014 | Jaguar Animal Health Raises $2M | Jaguar Animal Health, Inc., a San Francisco, CA-based company focused on the development and commercialization of health solutions for the global veterinary marketplace from plants used traditionally in rain forest areas, raised $2m in a Se... |
| 22.08.2013 | MicuRx Pharmaceuticals Raises $25M in Series B Financing | MicuRx Pharmaceuticals, Inc., a Hayward, CA-based biopharmaceutical company developing innovative antibiotics, raised $25m in Series B financing. The round was led by BVCF, with participation from existing investors Morningside Group and De... |